Citigroup Maintains Buy on Adient, Lowers Price Target to $29

Benzinga Newsdesk www.benzinga.com Negative 58.7%

Neg 58.7% Neu 0% Pos 0%

Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.

Comments

No comments yet. Be the first!